Bicara Therapeutics Inc. (NASDAQ:BCAX) is held by 137 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 6,955,993 | 0 | 0.00% | $117,069,362.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 5,216,969 | 0 | 0.00% | $87,801,588.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 3,575,000 | -1,525,000 | -29.90% | $60,167,250.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 3,401,838 | 2,937,111 | 632.01% | $57,254.00 |
| FMR LLC | 31 Dec, 2025 | 3,347,223 | 648,862 | 24.05% | $56,333,763.00 |
| Red Tree Management, LLC | 31 Dec, 2025 | 3,170,509 | 0 | 0.00% | $53,359,666.00 |
| TPG GP A, LLC | 31 Dec, 2025 | 3,010,425 | 0 | 0.00% | $50,665,453.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 2,646,285 | 2,646,285 | 0.00% | $44,484,051.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 2,614,004 | 187,347 | 7.72% | $43,993,687.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 2,528,451 | 216,662 | 9.37% | $42,553,826.00 |
| Omega Fund Management, LLC | 31 Dec, 2025 | 2,204,650 | 0 | 0.00% | $37,104,260.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,186,150 | -14,775 | -0.67% | $36,792,904.00 |
| State Street Corp | 31 Dec, 2025 | 1,649,537 | 1,059,260 | 179.45% | $27,761,708.00 |
| Franklin Resources Inc | 31 Dec, 2025 | 1,620,025 | 1,620,025 | 0.00% | $27,265,020.00 |
| Royalty Pharma Sub-Manager, LLC | 31 Dec, 2025 | 1,263,150 | 1,263,150 | 0.00% | $45,864,977.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 1,104,662 | 871,901 | 374.59% | $18,591,462.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 811,400 | -19,808 | -2.38% | $13,658,764.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 772,258 | 772,258 | 0.00% | $12,997,102.00 |
| FIL Ltd | 31 Dec, 2025 | 758,493 | -45,260 | -5.63% | $12,765,437.00 |
| ACORN CAPITAL ADVISORS, LLC | 31 Dec, 2025 | 643,382 | 0 | 0.00% | $10,828,113.00 |